Lack of cardiotoxicity of a new antineoplastic agent, a synthetic derivative of indenosiochinoline: Comparison with daunorubicin in rabbits

Archives of Toxicology

Volumn 70, Issue 10, 1996, Pages 645-651

  Geršl, Vladimír ^a   Mazurová, Yvona ^a   Bajgar, Jiří ^b   Mělka, Milan ^a   Hrdina, Radomir ^c   Palička, Vladimír ^d  

^a CHARLES UNIVERSITY   (Czech Republic)

^b DEPARTMENT OF TOXICOLOGY   (Czech Republic)

^c Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^d UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

11 dioxo 5,6 dihydro 11H indeno l,2 c isochinoline; 6 2 (2 hydro xyethyl)aminoethyl 5,; Cardiotoxicity; Daunorubicin; Histology; Hydrochloride (Oracin); Rabbit

Indexed keywords

ANTINEOPLASTIC AGENT; DAUNORUBICIN; ISOQUINOLINE DERIVATIVE; ORACIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; HISTOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; ANTINEOPLASTIC AGENTS; DAUNORUBICIN; ETHANOLAMINES; HEART; ISOQUINOLINES; MALE; RABBITS;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0029763085     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002040050324     Document Type: Article

References (22)

1. Acker SABE van. Kramer K, Grimbergen JA, Vijgh WJF van der, Bast A (1995) Doxorubicin-induced chronic cardiotoxicity measured in freely moving mice. In: Zeller WJ, Eisenbrand G, Hellmann K (eds) Reduction of anticancer drug toxicity. vol 48. Karger, Basel Freiburg Paris London New York New Delhi Bangkok Singapore Tokyo Sydney, pp 30-39
2. Bazett HC (1920) An analysis of the time-relations of the electrocar-diograms. Heart 7: 353-370
3. Cini Neri G, Neri B, Bandinelli M, Del Tacca M, Danesi R, Riccardi R (1991) Anthracycline cardiotoxicity: in vivo and in vitro effects on biochemical parameters and heart ultrastructure of the rat. Oncology 48: 327-333
4. Czarnecki CM (1984) Animal models of drug-induced cardio-myopathy. Comp Biochem Physiol 79C: 9-14
5. Elisson LO, Björkman S (1988) Congestive heart failure in rabbits after a single intrapleural administration of a low dose of doxorubicin or epirubicin. Pharmacol Toxicol 62: 84-89
6. Fu LX, Waagstein F, Hjalmarson A (1990) A new insight into adriamycin-induced cardiotoxicity. Int J Cardiol 29: 15 20
7. Geršl V (1994) Oracin (Project no 31 066) Final research report. Faculty of Medicine. Charles University. Hradec Kràlové. pp 1-48
8. Geršl V, Hrdina R (1994) Noninvasive polygraphic cardiac changes in daunorubicin-induced cardiomyopathy in rabbits. Sbor Vèd Praci LF UK Hradec Kràlové 37: 49-55
9. Gibbs CL, Woolley G, Kotsanas G, Gibson WR (1984) Cardiac energetics in daunorubicin-induced cardiomyopathy. J Mol Cell Cardiol 16: 953-962
10. Gibbs CL. Kotsanas G, Gibson WR (1986) Daunorubicin-induced cardiomyopathy in rabbits: isolated heart and papillary muscle energetics. J Mol Cell Cardiol 18: 273-282
11. Herman EH, Ferrans VJ (1986) Pretreatment with ICRF-187 provides long-lasting protection against daunorubicin cardiotoxicity in rabbits. Cancer Chemother Pharmacol 16: 102-106
12. Isberg B, Paul C, Jonsson L, Svahn U (1991) Myocardial toxicity of high-dose cyclophosphamide in rabbits treated with daunorubicin. Cancer Chemother Pharmacol 28: 171-180
13. Jandik J, Vokrouhlický L, Zeman V, Peregrin J, Kvasnička J. Šistek J, Bělobrádek Z, Baštecký J, Hlava A, Podrabský P. Vosečková A, Barták K, Hartman M, Zaydlar K (1982) Value of the noninvasive polygraphic tracing in patients with coronary heart disease. Sbor Věd Praci LF UK Hradec Králové 25: 487-573
14. Kozák P (1973) Vyšetřování srdeční dynamiky nepřímými metodami. Avicenum. Praha. p 38
15. Lee V, Randhawa AK, Singal P (1991) Adriamycin-induced myocardial dysfunction in vitro is mediated by free radicals. Am J Physiol 261: H989 995
16. Mělka M (1993) (ed) Oracin. Preclinical study. VÚFB, Praha. pp 1-461 (in Czech)
17. Odom AL, Hatwig CA, Stanley S. Benson AM (1992) Biochemical determinants of Adriamycin toxicity in mouse liver, heart and intestine. Biochem Pharmacol 43: 831-836
18. Reeves WC, Griffith JW, Wood MA, Whitesell L (1990) Exacerbation of doxorubicin cardiotoxicity by digoxin administration in an experimental rabbit model. Int J Cancer 45: 731-736
19. Schott G (1991) Systolic time intervals and echocardiography in monitoring adriamycin-trealed tumor patients. Z Gesamte Inn Med 46: 280-282
20. Sinha BK (1982) Myocardial toxicity of anthracyclines and other antitumour agents. In: Van Stee EW (ed) Cardiovascular toxicology. Raven Press, New York, pp 181-197
21. Weissler AM, Schoenfeld CD (1970) Effect of digitalis on systolic time intervals in heart failure. Am J Med Sci 259: 4-20
22. Woolf N (1992) Ischemia and infarction. In: McGee JO'D. Isaacson PG, Wright NA (eds) Oxford textbook of pathology, vol 1. Oxford University Press. Oxford New York Tokyo, pp 525-530